Pieter Jelle Visser

Research interests

Publications

• Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

  JAMA Neurology · 2022 · 10.1001/jamaneurol.2021.5216

• Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

  Alzheimer s & Dementia · 2019 · https://doi.org/10.1016/j.jalz.2019.04.001

• Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

  JAMA Neurology · 2019 · https://doi.org/10.1001/jamaneurol.2019.1534

• Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia

  Alzheimer s & Dementia · 2018 · 10.1016/j.jalz.2018.10.003

• Consensus guidelines for lumbar puncture in patients with neurological diseases

  Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 10.1016/j.dadm.2017.04.007

• Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

  The Lancet Neurology · 2017 · https://doi.org/10.1016/s1474-4422(17)30159-x

• Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

  The World Journal of Biological Psychiatry · 2017 · 10.1080/15622975.2017.1375556

• Suspected non-Alzheimer disease pathophysiology — concept and controversy

  Nature Reviews Neurology · 2016 · 10.1038/nrneurol.2015.251

• Prevalence of Amyloid PET Positivity in Dementia Syndromes

  JAMA · 2015 · https://doi.org/10.1001/jama.2015.4669

• Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

  JAMA · 2015 · https://doi.org/10.1001/jama.2015.4668

• Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

  Brain · 2015 · 10.1093/brain/awv029

• Optimizing Patient Care and Research: The Amsterdam Dementia Cohort

  Journal of Alzheimer s Disease · 2014 · 10.3233/jad-132306

• A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

  Alzheimer s & Dementia · 2014 · https://doi.org/10.1016/j.jalz.2014.01.001

• The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?

  Alzheimer s & Dementia · 2014 · 10.1016/j.jalz.2013.12.023

• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

  The Lancet Neurology · 2014 · https://doi.org/10.1016/s1474-4422(14)70090-0

• Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

  The Lancet Neurology · 2013 · 10.1016/s1474-4422(13)70194-7

• Recommendations to Standardize Preanalytical Confounding Factors in Alzheimer’s and Parkinson’s Disease Cerebrospinal Fluid Biomarkers: An Update

  Biomarkers in Medicine · 2012 · 10.2217/bmm.12.46

• Revising the definition of Alzheimer's disease: a new lexicon

  The Lancet Neurology · 2010 · https://doi.org/10.1016/s1474-4422(10)70223-4

• Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

  The Lancet Neurology · 2009 · 10.1016/s1474-4422(09)70139-5

• Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

  The Lancet Neurology · 2007 · https://doi.org/10.1016/s1474-4422(07)70178-3

• Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment

  Neurology · 2004 · 10.1212/01.wnl.0000133114.92694.93

• Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

  Journal of Internal Medicine · 2004 · https://doi.org/10.1111/j.1365-2796.2004.01380.x

• Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease

  NeuroImage · 2004 · 10.1016/j.neuroimage.2004.07.006

• Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.

  PubMed · 2002 · 10.1136/jnnp.72.4.491

• Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment

  Journal of Neurology · 1999 · 10.1007/s004150050387

Current projects

No projects listed.